Skip to main content

Closed

HQL: Tekla Life Sciences Investors Financial Statements & Revenue | finqOS

Financial Services · Asset Management

52W Range

73thpctl

Volume

1.09×avg

Market Cap

580.79MUSD

P/E Ratio

2.8TTM

Div Yield

10.68%ann

Tekla Life Sciences Investors

HQLNew York Stock Exchange·USD·Closed

Tekla Life Sciences Investors

HQLNew York Stock Exchange·USD·Closed

$19.10

−1.75%

$19.10

−$0.34 (1.75%)

52W Range

73thpctl

Volume

1.09×avg

Mkt Cap

580.79MUSD

P/E

2.8TTM

Div Yield

10.68%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings